| Beulah Dental Weiss Pc | |
|
200 W Main St Beulah ND 58523-6970 | |
| (701) 873-2259 | |
| Not Available |
| Full Name | Beulah Dental Weiss Pc |
|---|---|
| Speciality | Clinic/center - Dental |
| Location | 200 W Main St, Beulah, North Dakota |
| Authorized Official Name and Position | Jessica Weiss (PRESIDENT) |
| Authorized Official Contact | 7018732259 |
| Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
| Mailing Address | Practice Location Address |
|---|---|
| Beulah Dental Weiss Pc Po Box 819 Beulah ND 58523-0819 Ph: (701) 873-2259 | Beulah Dental Weiss Pc 200 W Main St Beulah ND 58523-6970 Ph: (701) 873-2259 |
| NPI Number | 1255706933 |
|---|---|
| Provider Enumeration Date | 12/07/2015 |
| Last Update Date | 12/10/2015 |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255706933 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261QD0000X | Clinic/center - Dental | 2252 (North Dakota) | Primary |
News Archive
For the more than 45 million Americans who suffer from chronic headaches, relief may be on the way in the form of an electric pulse, according to a study presented at the ANESTHESIOLOGY 2013 annual meeting.
Administration of the active compound tetrahydroxystilbene glucoside (TSG) derived from the Chinese herbal medicine Polygonum multiflorum Thunb, reversed both overexpression of α-synuclein, a small protein found in the brain, and its accumulation using a mouse model of Alzheimer's disease.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that although platinum-based treatment will continue to be the standard of care for first- and second-line treatment of platinum-sensitive ovarian cancer, pegylated liposomal doxorubicin (PLD)/carboplatin will replace paclitaxel/carboplatin as the standard second-line treatment for patients who remain platinum sensitive.
Rhythm announced today the initiation of two Phase 2 clinical trials focused on evaluating the safety and effectiveness of setmelanotide (RM-493), the company's novel melanocortin 4 receptor (MC4R) agonist, for the treatment of Prader-Willi Syndrome (PWS) and POMC-null obesity.
› Verified 7 days ago
Beulah Dental Pc Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 200 W Main St, Beulah, ND 58523 Phone: 701-873-2259 |